Tag Archives: Patty Murray
A Weekly Advocacy Message from Mary Woolley: Moving from the Envy of the World to the Puzzle of the World
Dear Research Advocate:
NIH Director Francis Collins was recently interviewed for a Wall Street Journal article that would reinvigorate even the weariest research advocate. Dr. Collins captured the legacy and unprecedented potential of research for health, as well as the counterintuitive neglect of it, in a truly compelling manner. Dr. Collins made similarly captivating comments yesterday at the Washington Ideas Forum: “We’re going from the envy of the world,” he said, “to the puzzle of the world. Other nations are mystified that we have stopped following our own playbook — the one they are using now to drive their economy and improve health and quality of life for their own populations.”
Of course they’re mystified. Policy makers are setting Americans up for needless suffering and America up for decline. It’s past time to follow the lead of, for example, the Australian government; despite battling austerity, it has announced an increase in funding for the Australian Research Council’s research grants. And Australia is not alone — China is now on track to overtake U.S. spending (actual spending and as a percentage of GDP) within five years. Continue reading →
Dear Research Advocate:
Yesterday, the Budget Conference Committee, chaired by Sen. Patty Murray (D-WA) and Rep. Paul Ryan (R-WI-01), met for the first time. The committee only has until December 13 to accomplish its task of producing at least a short-term budget. Expectations are modest considering the short timeline, the House and Senate recess schedules, and the number of issues declared “off the table.” There is some talk of replacing sequestration, at least for the remainder of FY14, with selected cuts. In order to assure that research is not cut and in fact is prioritized for an increase, many stakeholders must speak up. It is essential that our issue is discussed as a priority every day in this 43-day countdown — in the media, in hometown districts, by staffers and by our elected officials. Please be sure to speak out. Urge your Members of Congress to advocate on your behalf — and on behalf of all who are depending on research for health — to their colleagues on the Budget Conference Committee.
Sequestration really must go! Useful facts to bolster our case about how sequestration is stalling scientific R&D in this country — to the detriment of business and consumers alike — is now at the ready. Columnist Gerald F. Seib of The Wall Street Journal points to many consumer products and their components that have origins in federally supported basic research, adding billions of dollars to our economy over the decades. And the Science Coalition has released a new report Sparking Economic Growth 2.0 highlighting 100 companies whose beginnings were aided by federally funded university research. Think of Google’s roots in NSF funding and Genentech’s in NIH, for just two prominent examples. The report describes the role these research-based companies play in bringing transformative innovations to market, creating jobs and contributing to economic growth. It’s all too easy to forget, once a business is thriving, how taxpayer funding helped them get its start. Continue reading →
Op-ed by Abigail Schindler, PhD, postdoctoral fellow at the University of Washington, Department of Psychiatry and Behavioral Sciences and co-leader of the Seattle Forum on Science Ethics and Policy published in The Seattle Times.
When I think about not being a scientist anymore my heart hurts. But sadly, due to continued budget cuts to biomedical research, within the next few years that is most likely exactly what I will be — no longer a scientist, no longer a researcher searching for cures for disease.
And I am not alone. The number of young scientists being forced out of basic biomedical research in the United States is increasing at an alarming rate, and when this next generation of scientists leaves, it is not coming back.
Like me, these are early career scientists trained in the United States by U.S. tax dollars. We are scientists whose life goal has been to one day have our own research program at an academic institution committed to the search for breakthroughs and cures. Yet because of these budget cuts, catchphrases such as the “brain drain” are proving true. This is a bad omen for U.S. global leadership in biomedical research and the future health and wellness of our nation.
The National Institutes of Health (NIH) is the nation’s premier biomedical research agency and the leading supporter of biomedical research in the world. Despite numerous public polls showing strong support among Americans for government funding of basic biomedical research, NIH’s budget was cut by $1.5 billion this year, or 5 percent, from $31 billion. Continue reading →